Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · 77 citations · 28 references
MedicineNeurologyNeuroscienceDementiaNeurodegenerationNeuropsychiatryAlzheimer DiseaseBiomarkers Of NeurodegenerationBrain ImagingDown SyndromeNeurodegenerative DiseasesNeurodegenerative DisordersAlzheimer Disease ProgressionAmyloid Pet ImagingConvertersDecay-corrected Standardized Uptake ValueNeuroimaging MarkersPositron Emission Tomography DiagnosisQuantitative Uptake RatiosVolumetric Imaging
INTRODUCTION: Down syndrome (DS) arises from a triplication of chromosome 21, causing overproduction of the amyloid precursor protein and predisposes individuals to early Alzheimer's disease (AD). METHODS: C]PiB) and T1 weighted magnetic resonance imaging (MRI) scans 3.0 ± 0.6 years apart. Standard uptake value ratio (SUVR) images (50-70 minutes; cerebellar gray matter [GM]) and GM volumes were analyzed in standardized space (Montreal Neurological Institute space). RESULTS: 85% of PiB(-) subjects remained PiB(-), whereas 15% converted to PiB(+), predominantly in the striatum. None reverted from PiB(+) to PiB(-). Increases in SUVR were distributed globally, but there were no decreases in GM volume. The PiB positivity groups differed in the percent rate of change in SUVR [PiB(-): 0.5%/year, PiB converters: 4.9%/year, and PiB(+): 3.7%/year], but not in GM volume. DISCUSSION: Despite the characteristic striatum-first pattern, the global rate of amyloid accumulation differs by pre-existing amyloid burden and precedes atrophy or dementia in the DS population, similar to general AD progression.
28
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Dietmar Rudolf Thal, Udo Rüb, M Orantes et al. · Neurology · 2002 · 3.5K citations
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Liesi E. Hebert, Jennifer Weuve, Paul A. Scherr et al. · Neurology · 2013 · 2.7K citations · Full text